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ABSTRACT
Background The effectiveness of salt restriction to
lower blood pressure (BP) in Bangladeshi patients with
chronic kidney disease (CKD) is uncertain.
Objective To test the hypothesis that a tailored
intervention intended to reduce salt intake in addition to
standard care will achieve a greater reduction in BP in
UK Bangladeshi patients with CKD than standard care
alone.
Design A randomised parallel-group controlled trial
conducted over a 6 month period.
Setting A tertiary renal unit based in acute care
hospital in East London.
Participants 56 adult participants of Bangladeshi
origin with CKD and BP >130/80 mm Hg or on
antihypertensive medication.
Intervention Participants were randomly allocated to
receive a tailored low-salt diet or the standard low-salt
advice. BP medication, physical activity and weight were
monitored.
Main outcome measures The primary outcome was
change in ambulatory BP. Adherence to dietary advice
was assessed by measurement of 24 h urinary salt
excretion.
Results Of 56 participants randomised, six withdrew at
the start of the study. During the study, one intervention
group participant died, one control group participant
moved to Bangladesh. Data were available for the
primary endpoint on 48 participants. Compared with
control group the intervention urinary sodium excretion
fell from 260 mmol/d to 103 mmol/d (−131 to −76,
p<0.001) at 6 months and resulted in mean (95% CI)
falls in 24 h systolic/diastolic BP of −8 mm Hg (−11 to
−5)/2 (−4 to −2) both p<0.001.
Conclusions A tailored intervention can achieve
moderate salt restriction in patients with CKD, resulting
in clinically meaningful falls in BP independent of
hypertensive medication.
Trial Registration ClinicalTrials.gov NCT00702312.
INTRODUCTION
Chronic kidney disease (CKD) prevalence is three
to ﬁve times higher in the Bangladeshi population
compared with other ethnic groups in the UK.1
Hypertension is the cause and consequence of
CKD2 and extracellular volume expansion is an
important factor in the development and mainten-
ance of hypertension in patients with CKD.3 The
British Bangladeshi population has an unusually
high salt intake, twice that of the general popula-
tion, which might contribute to CKD and hyper-
tension.4 An intake of less than 6 g salt/d
(∼100 mmol Na/d)5 is advised in the UK and
Europe based on the association of salt intake with
blood pressure (BP) and cardiovascular disease
rather than the much lower intake required to
prevent sodium deﬁciency. However, even greater
restrictions to below 60 mmol Na/d have been pro-
posed in NICE guidelines. Nevertheless, a recent
systematic review suggested an adverse effect of
intakes as low as 3.5 g/d.6 Meta-analyses of salt
restriction studies show a greater BP lowering effect
of salt restriction in hypertensive compared with
normotensive subjects; under optimal conditions
reductions in systolic/diastolic BP of 7/4 mm Hg7
can be obtained with salt intake reduced to
100 mmol/d. Patients with resistant hypertension,
deﬁned as BP that remains above target despite the
use of three or more antihypertensive medications,8
are thought to be salt sensitive.9 However, adher-
ence to dietary advice is often poor resulting in
smaller changes (<1mm Hg) in BP of dubious clin-
ical value. In previous work we investigated barriers
to dietary salt restriction in Bangladeshi patients
with CKD in East London10 and developed a strat-
egy intended to reduce salt intake in these patients.
This present study set out to test the hypothesis
that a low-salt educational intervention tailored to
meet the needs, customs and practices of this popu-
lation in addition to standard hypertension medica-
tion management would result in greater BP
reduction than standard care alone: a ﬁrst such
intervention with this population group.
METHODS
A parallel-group randomised trial design was
selected, and conducted between June 2008 and
July 2009. Ethical approval was obtained from the
relevant research ethics committee.
Participants were patients with established mod-
erate–severe CKD of Bangladeshi origin residing in
East London, UK. Inclusion criteria were estimated
glomerular ﬁltration rate (eGFR) <60 mL/min and
mean BP >130/80 mm Hg on at least two clinic
visits or taking antihypertensive medication.
Patients on dialysis, those with a body mass index
<20 or >35 kg/m2, urinary incontinence, or
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cognitive impairment or mental problems impairing their ability
to participate were excluded.
Participants were recruited at the predialysis clinic of a ter-
tiary renal unit in London by the researcher. Randomisation to
treatment was conducted by the study statistician using
computer-generated random blocks with block sizes between
four and eight and the group assignment given to the researcher.
This was a dietary behaviour intervention, thus, neither partici-
pants nor the dietitian administering the intervention could be
blinded to treatment allocation. Data analysis was conducted by
the study statistician who was blinded to treatment allocation.
Intervention
The intervention group was initially advised by the study diet-
itian at the hospital clinic followed by practical cooking and
educational sessions in the community facilitated by Bengali
workers and attended by the researcher (see online supplemen-
tary ﬁle). Community cooking sessions were delivered in con-
junction with Community Kitchen UK.11 In the community
sessions, intervention participants cooked two versions of their
traditional meals: one followed their usual recipe, the other had
salt reduced by 50%. Fortnightly telephone calls from a Bengali
worker followed, to reinforce advice and set new targets. The
control group received usual care from the renal clinic in the
form of a low sodium general dietary advice sheet sent by post
with the physician’s letter. This had not been speciﬁcally
adapted for Bangladeshi diets.
Data collection
Data collected at enrolment included age, sex, medication use
and comorbidities, including diabetes mellitus. Data collection
for the primary outcome was by ambulatory BP measured using
TM-2430-13 devices (A&D Medical, Milpitas, California, USA;
graded A/A by the British Hypertension Society) and Doctor
Pro software, in accordance with recommendations.12 Daytime
measurements were taken at 30 min intervals, night-time mea-
surements every 60 min. Height, weight and body composition
(total body water) were measured using the Fresenius Medical
Care D GmbH Body Composition Monitor; blood samples
were obtained for glycosylated haemoglobin (HbA1c). Physical
activity levels were recorded using the YamaxDigi-Walker
SW-200 (Yamax Corporation, Tokyo, Japan) pedometer, shown
to have an overall mean absolute error of 3% for outdoor
normal walking.13 The accuracy of the pedometer on each par-
ticipant was checked by a 20-step test at the outset, with an
acceptance criterion of ±2 steps.13 Data were collected at two
time points, at baseline and at end of study—6 months later.
Outcomes
The primary outcome was reduction in systolic BP (SBP) deter-
mined by 24 h ambulatory monitoring. Secondary outcomes
were changes in diastolic BP and reduction in eGFR.
Measurement of 24 h urinary sodium, potassium and creatine
were undertaken using routine methods at baseline and
follow-up as indices of adherence to the intervention and deter-
mined by assessors blinded to treatment allocation.
Statistical analysis
Sample size calculations were based on a sample of 25 partici-
pants per group giving 80% power to detect a signiﬁcant reduc-
tion in the mean SBP of 8 mm Hg at p<0.05 between the two
groups (which was regarded as clinically relevant difference),
assuming a SD of 10 mm Hg.14 Sample size was increased to 26
per group to allow for non-compliance or dropout. Analyses
were conducted on an intention-to-treat basis. Changes within
groups between baseline and follow-up at 6 months were com-
pared using analysis of covariance and results are expressed as
mean values with 95% CIs using Stata V.10 (StataCorp LP,
Texas, USA).
RESULTS
Participant recruitment and progress through the trial is shown
in ﬁgure 1. Of the 56 participants recruited six withdrew; three
cited the inconvenience of 24 h urine collection, two were
unwilling to undergo ambulatory BP monitoring and one was
unwilling to attend the community cooking activity. One inter-
vention group participant died; one control group member relo-
cated to Bangladesh. Data were available for 48 participants.
Details are shown in table 1; groups were well-matched includ-
ing for antihypertensive medication, with most receiving ACE
inhibitor or angiotensin-receptor blocking medicines and
diuretics.
Adherence to the dietary intervention
All participants attended the initial brieﬁng session with the
study dietitian. Male participants attended with their wives,
daughters or sisters while female participants attended with
their daughters or daughters-in-law. Participants were split into
four groups of six or seven to attend the community cooking
sessions; each group was to attend two weekly consecutive ses-
sions. Male participants chose not to attend but sent a female
representative; a wife, daughter or sister for single men. The
ﬁrst weekly session was attended by 88% (23/25) of the partici-
pants or representatives; the second and ﬁnal session was
attended by 84% (21/25). Overall, all participants attended at
least one cooking session.
Adherence to dietary salt recommendations was indicated by
urinary sodium excretion. At baseline urinary sodium excretion
was approximately 260 mmol/24 h in both groups (ﬁgure 2).
After 6 months, this had reduced by 122 mmol/24 h (95% CI
−140 to −105, p<0.001) in the intervention group, and by
13 mmol/24 h (95% CI −18 to −8, p<0.001) in the control
group. At follow-up sodium excretion differed signiﬁcantly
between groups, by 103 mmol (95% CI −131 to −76, p<0.001).
Primary and secondary outcomes
Systolic BP was elevated in both groups at baseline but fell by
8 mm Hg (95% CI 5 to 11, p=0.0003) on tailored intervention
compared with the usual care group. Figure 3 shows the signiﬁ-
cant (p<0.001) falls in daytime and night systolic and diastolic
BP in the intervention group compared with the control group.
Non-dipping, that is loss of the normal nocturnal reduction in
night-time SBP, with a difference >10 mmHg between night-
time and daytime SBP, was observed in 60% (15/25) of the inter-
vention group and 56% (13/23) of the control group at baseline.
At follow-up this reduced by 40% (6/25; p=0.02) in the inter-
vention group but remained unchanged in the control group.
The observed changes in eGFR from baseline to follow-up
were similar for both groups. An eGFR decline of 3.0 (95% CI
0.1 to 6.0) and 3.4 (95% CI 1.0 to 5.7) mL/min per 1.73 m2
were observed in the intervention and control groups
respectively.
Covariate ﬁndings
Potassium excretion was low (40 mmol/d) in both groups and
unchanged at follow-up. Physical activity levels were low in
both groups and remained unchanged during the study.
Glycosylated haemoglobin concentrations remained elevated at
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>8.0%, indicating poor but unchanging diabetic control in both
groups. Body weight did not change in either group, but there
was a modest but statistically signiﬁcant reduction in mean
total body water in the intervention group (0.50 L, p<0.01)
compared with no change in the control group (0.26 L, not stat-
istically signiﬁcant.).
DISCUSSION
Dietary advice to lower salt intake is routinely given to patients
with CKD in the form of an information sheet; this study sug-
gests this is ineffective at changing behaviour. By contrast, the
dietitian-led intervention which identiﬁed the sources of salt in
the Bangladeshi diet and developed strategies to lower intake,
achieved a reduction in dietary salt intake of over 100 mmol/d.
While mean urinary sodium excretion still remained well above
the UK target of 100 mmol/day,15 postintervention group results
Figure 1 CONSORT ﬂow chart of participant recruitment, allocation and assessment.





Mean SD Mean SD
Age (y) 60.7 12.0 55.7 15.1
Male : female (No) 14 : 9 14 : 11
Mean 24 h systolic BP mm Hg 156.0 10.7 149.3 15.2
Mean 24 h diastolic BP mm Hg 85 5.8 85 6.3
Diabetes (%) 14 (60) 17 68
Glycosylated Hb (%) 8.6 1.8 8.9 1.9
GFR mL/min/1.73 m2 42 15.3 41 17.2
Urinary sodium mmol/24 h 259 47.1 263 54.0
Urinary potassium mmol/24 h 39 6.9 43 4.0
Urinary creatine mmol/24 h 11.15 1.9 10.75 1.3
No of BP medications/patient* 3 (2,4) 3 (2,4)
Total body water (kg) 33.1 5.9 33.4 5.2
BMI (kg/m2) 27.1 5.2 26.6 5.4
Physical activity (steps/day)* 2,534 1,101 2,471 1,419
No statistical significant differences between the two groups.
*Median with IQR.
BMI, body mass index; BP, blood pressure; GFR, glomerular filtration rate, Hb,
haemoglobin.
Figure 2 24 h urinary sodium excretion for intervention and control
groups is shown as the mean difference with 95% CI in parenthesis. All
differences are p<0.001. Control n=23, Intervention n=25.
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were more similar to those seen in the UK white population.
This reduction in salt intake led to a highly signiﬁcant fall of 8/
3 mm Hg in BP; very close to the ﬁgure predicted by
meta-analyses.7
The dietary approach used has also been shown to be effect-
ive in BP reduction with other ethnic groups with high dietary
salt intakes.16 Behavioural intervention studies have previously
demonstrated that knowledge is a key contributing factor to
adherence to low-salt diet14 and that lack of knowledge is a key
barrier in dietary modiﬁcation and adherence.17 18 However,
knowledge of the need to reduce dietary salt intake is not
always enough to ensure dietary modiﬁcation and adherence.
This study shows that knowledge tailored to recipients’ needs
and contexts, delivered in a practical and acceptable manner,
can effect behavioural change and achieve health beneﬁts.
Our previous studies showed that Bangladeshi patients with
CKD have much higher intakes of salt than the general popula-
tion, with much of the salt being added during home prepar-
ation of food rather than during processing, as is the case in the
general population. Consequently, routine advice for salt reduc-
tion designed for predominantly white European populations
was not appropriate for this group of patients, for whom the
engagement of family members was crucial. This was particu-
larly relevant for these study participants, who almost exclu-
sively ate home-prepared meals in family groups.
We noted that over half of the Bangladeshi patients with
CKD had raised BP throughout the day and night: the ‘non-
dipping’ effect. Previously ‘non-dipping’ prevalence has been
found to increase with worsening CKD, with 15% of normal
subjects affected increasing to 75% in those with stage ﬁve
CKD.19 Non-dipping has been associated with increased
target-organ damage (heart, brain, kidney),20–22 raised fre-
quency of stroke and myocardial infarction,23 and higher car-
diovascular mortality.22 Decreased salt intake and urinary
sodium excretion led to greater reduction in night-time SBP
compared with daytime, and the restoration of the normal
physiological night-time dip in BP in many patients. In black
salt-sensitive patients with hypertension salt restriction improved
the circadian rhythm of BP with a return to dipping pattern.24
Our study conﬁrmed that salt reduction can change the pattern
from ‘non-dipper’ to ‘dipper’, and a recent review has
concluded that the South Asian population is salt sensitive.25 A
return to a ‘dipping’ BP pattern may lead to a signiﬁcant reduc-
tion in the risk of vascular events for this patient group but
long-term follow-up is required to demonstrate this.
Comparison with other studies
Data supporting our ﬁndings were reported by MacGregor
et al,26 who demonstrated that when urinary sodium excretion
dropped by 100 mmol/24 h, subjects supine BP declined by
8/5 mm Hg (p<0.01); a sodium reduction of 150 mmol/24 h
led to a larger decline of 16/9 mm Hg. Similarly, a modest salt
reduction of 50 mmol/24 h (from a much lower baseline than in
our participants: an average of 177 mmol/24 h) resulted in
7/3 mm Hg drop in BP in a randomised trial in older people.27
A recent meta-analysis of 17 trials in hypertensive individuals
over ≥4 weeks supports the approximate magnitude of this
effect.7 A recent study of modest dietary sodium restriction in
patients receiving ACE medicines showed 11mm Hg reduction
in SBP in non-diabetic nephropathy.28 Our study conﬁrms this
magnitude of association between reduction in sodium excretion
and BP values. Moreover, our study is the ﬁrst study to our
knowledge of a population with CKD with traditionally high
salt intake and hypertension with a follow-up period of
6 months suggestive of sustained beneﬁt in the tailored interven-
tion approach.
Strengths and limitations
The strength of this study is that it delivered an effective salt
reduction dietary intervention for this group of patients, and
demonstrated participants’ adherence to dietary advice through
24 h urinary sodium excretion. However, only single 24 h urine
collections and 24 h ambulatory BP recordings were made.
Further, treatment allocation could not be blinded. Therefore,
ambulatory BP readings were analysed centrally in the hyperten-
sion unit by a statistician who was blinded to the treatment allo-
cation. Hence the results were relatively less likely subject to
bias. It remains uncertain whether reducing BP may translate
into slowing of disease progression or reduction in cardiovascu-
lar events.
Applicability and generalisability
The Bangladeshi population and indeed the South Asian group
are known for a high dietary salt intake, are at a high risk of
CKD and thus, hypertension development. Dietary salt reduc-
tion can safely and usefully be extended to other family
members who may in time also be at risk of developing hyper-
tension. Other ethnic groups with a high prevalence of CKD
and hypertension, such as black African and Afro-Caribbean
populations, may also beneﬁt from tailored dietary interventions
to reduce salt intake.
CONCLUSION
This study demonstrates the importance of tailoring dietary
advice to patients’ contexts, cultures and needs, particularly for
minority and high-risk groups. Healthcare professionals need
education and training in methods to enable them to translate
generic principles of healthy living and health promotion in
such a way as to successfully deliver education and promote its
application in the daily lives of their patients. Policy makers
need to recognise the importance of resourcing complementary
approaches to medication for effective BP control. An integrated
approach, drawing on multiple successful approaches to hyper-
tension reduction, offers the best option for BP management in
patients with CKD.
Figure 3 Changes in daytime and night-time systolic blood pressure
(SBP) and diastolic blood pressure (DBP). Mean values and changes
with 95% CI. All differences are p<0.001. Control n=23, Intervention
n=25.
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